ArticleBlood advances2022

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA.

Mika Casey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.